Final dividend Royal DSM
(Thomson Reuters ONE) -
The DSM Annual General Meeting of Shareholders on 30 April 2015 passed a
resolution to declare a dividend for the financial year 2014 of ?1.65 per
ordinary share of ?1.50 par value. An interim dividend of ?0.55 per ordinary
share having been paid in August 2014, the final dividend for the financial year
2014 will amount to ?1.10 per ordinary share.
This final dividend of ?1.10 will be paid out in cash or in the form of ordinary
shares at the option of the shareholder. Dividend in cash will be paid after
deduction of 15% Dutch dividend withholding tax. The ex-dividend date on
Euronext Amsterdam will be 5 May 2015 and the record date will be 6 May 2015.
Shareholders have from 7 May until 20 May 2015 (3.00 pm CET) to indicate if they
wish to receive their dividend in the form of ordinary shares, otherwise it will
be distributed in cash. On 21 May 2015 after the close of trading on Euronext
Amsterdam the number of dividend rights of ordinary shares entitling the holder
to one ordinary share will be determined.
This exchange ratio will be based on the volume weighted average price of all
ordinary shares in DSM traded at Euronext Amsterdam on 14 May 2015 up to and
including 20 May 2015. The value of the stock dividend will be virtually equal
to the value of the cash dividend. The ordinary shares that constitute the stock
dividend are entitled to any dividend for the financial year 2015 and to the
dividends for subsequent financial years. Stock dividend rights will not be
traded on Euronext Amsterdam.
The following timetable applies:
5 May 2015: Ex-dividend quotation
6 May 2015: Record Date
7 May 2015 - 20 May 2015 (3.00 pm CET): Period in which shareholders can
indicate their choice
21 May 2015 (COB): Announcement of the exchange ratio
27 May 2015: Delivery of shares or cash payment
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders simultaneously. DSM
delivers innovative solutions that nourish, protect and improve performance in
global markets such as food and dietary supplements, personal care, feed,
medical devices, automotive, paints, electrical and electronics, life
protection, alternative energy and bio-based materials. DSM and its associated
companies deliver annual net sales of about ?10 billion with approximately
25,000 employees. The company is listed on Euronext Amsterdam. More information
can be found at www.dsm.com.
Or find us on:
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Dave Huizing
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
e-mail media.contacts(at)dsm.com e-mail investor.relations(at)dsm.com
Press release-pdf:
http://hugin.info/130663/R/1917488/686100.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via GlobeNewswire
[HUG#1917488]
Unternehmensinformation / Kurzprofil:
Datum: 30.04.2015 - 18:15 Uhr
Sprache: Deutsch
News-ID 389974
Anzahl Zeichen: 3972
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 138 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Final dividend Royal DSM"
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
